M Laughon

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Fluconazole pharmacokinetics and safety in premature infants
    K Turner
    Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Curr Med Chem 19:4617-20. 2012
  2. pmc Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasia
    Sara E Massie
    School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Health Qual Life Outcomes 9:55. 2011
  3. pmc Prevention of bronchopulmonary dysplasia
    Matthew M Laughon
    UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Semin Fetal Neonatal Med 14:374-82. 2009
  4. pmc Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants
    Matthew M Laughon
    Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599 7596, USA
    Am J Respir Crit Care Med 183:1715-22. 2011
  5. pmc Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation
    Matthew Laughon
    Division of Neonatal Perinatal Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599 7596, USA
    Pediatrics 124:637-48. 2009
  6. pmc Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks
    Matthew Laughon
    Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Pediatr Res 70:292-6. 2011
  7. pmc Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants
    Matthew Laughon
    Division of Neonatal Perinatal Medicine, University of North Carolina, Chapel Hill, NC 27599 7596, USA
    Pediatrics 123:1124-31. 2009
  8. doi request reprint A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia
    Matthew Laughon
    School of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Pediatrics 123:89-96. 2009
  9. pmc Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week
    Matthew Laughon
    School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatrics 119:273-80. 2007
  10. ncbi request reprint Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes
    M Laughon
    Division of Neonatal Perinatal Medicine, School of Medicine, The University of North Carolina at Chapel Hill, USA
    J Perinatol 27:164-70. 2007

Collaborators

Detail Information

Publications18

  1. pmc Fluconazole pharmacokinetics and safety in premature infants
    K Turner
    Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Curr Med Chem 19:4617-20. 2012
    ..Additionally, fluconazole appears to be safe to use in this population, with only minimal reversible hepatobiliary effects...
  2. pmc Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasia
    Sara E Massie
    School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Health Qual Life Outcomes 9:55. 2011
    ....
  3. pmc Prevention of bronchopulmonary dysplasia
    Matthew M Laughon
    UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    Semin Fetal Neonatal Med 14:374-82. 2009
    ..However, each will need to be tested in randomized, controlled trials, and the expectations of new therapies should be modest reductions of the incidence of the disease...
  4. pmc Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants
    Matthew M Laughon
    Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599 7596, USA
    Am J Respir Crit Care Med 183:1715-22. 2011
    ....
  5. pmc Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation
    Matthew Laughon
    Division of Neonatal Perinatal Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599 7596, USA
    Pediatrics 124:637-48. 2009
    ..Extremely low gestational age newborns (ELGANs) are at increased risk of chronic lung disease (CLD) and of developmental delay. Some studies have suggested that CLD contributes to developmental delay...
  6. pmc Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks
    Matthew Laughon
    Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Pediatr Res 70:292-6. 2011
    ..Inflammation might influence the risk of EPPD and PD or be a consequence of lung damage or therapies to minimize lung dysfunction...
  7. pmc Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants
    Matthew Laughon
    Division of Neonatal Perinatal Medicine, University of North Carolina, Chapel Hill, NC 27599 7596, USA
    Pediatrics 123:1124-31. 2009
    ..We evaluated the antecedents and correlates of patterns of early lung disease, with particular emphasis on pulmonary deterioration, in a large cohort study (the Extremely Low Gestational Age Newborn [ELGAN] study)...
  8. doi request reprint A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia
    Matthew Laughon
    School of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Pediatrics 123:89-96. 2009
    ....
  9. pmc Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week
    Matthew Laughon
    School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatrics 119:273-80. 2007
    ....
  10. ncbi request reprint Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes
    M Laughon
    Division of Neonatal Perinatal Medicine, School of Medicine, The University of North Carolina at Chapel Hill, USA
    J Perinatol 27:164-70. 2007
    ....
  11. doi request reprint Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants
    Matthew Laughon
    Division of Neonatal Perinatal Medicine, School of Medicine, UNC Hospital, Chapel Hill, NC 27599 7596, USA
    Arch Dis Child Fetal Neonatal Ed 96:F114-20. 2011
    ..The incidence of chronic lung disease (CLD) varies among groups defined by their early pattern of respiratory disease...
  12. doi request reprint Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit
    K Herrman
    Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Arch Dis Child Fetal Neonatal Ed 94:F48-50. 2009
    ....
  13. pmc Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation
    Carl Bose
    Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Pediatr Res 69:347-53. 2011
    ..By contrast, mechanical ventilation altered protein levels and may be associated with systemic inflammation..
  14. pmc Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation
    Carl Bose
    Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatrics 124:e450-8. 2009
    ..There is now increasing interest in exposures and events before delivery that predict CLD. The objective of this study was to identify current prenatal predictors of CLD...
  15. doi request reprint Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial
    Mario Augusto Rojas
    Vanderbilt University, Division of Neonatal Perinatal Medicine, Department of Pediatrics, Nashville, TN 37232 2370, USA
    Pediatrics 123:137-42. 2009
    ..Administration of very early surfactant during a brief period of intubation to infants treated with nasal continuous positive airway pressure may improve their outcome and further decrease the need for mechanical ventilation...
  16. pmc Repeat lumbar punctures in infants with meningitis in the neonatal intensive care unit
    R G Greenberg
    Department of Pediatrics, Duke University, Durham, NC, USA
    J Perinatol 31:425-9. 2011
    ....
  17. doi request reprint Comparison of noninvasive and central arterial blood pressure measurements in ELBW infants
    R Troy
    Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7596, USA
    J Perinatol 29:744-9. 2009
    ..The objective of this study was to evaluate the difference between noninvasive and central arterial blood pressure measurements in extremely low-birth-weight (ELBW) infants...
  18. ncbi request reprint Treatment to prevent patency of the ductus arteriosus: beneficial or harmful?
    Carl L Bose
    J Pediatr 148:713-4. 2006